Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Stock Market Today & Weak Retail Earnings

Published 05/12/2017, 01:28 AM
Updated 07/09/2023, 06:31 AM

Friday, May 12, 2017

A combination of soft economic readings and some more weak earnings reports from traditional retailers are weighing on stocks today. The April Retail Sales and CPI readings this morning came in weaker than expected, though the prior-month’s Retail Sales growth pace did get revised higher.

The run of April data in recent days, the first set of numbers for the second quarter, is showing a rebound in the U.S. economy’s growth rate from the first quarter’s sub-par pace, but the extent of the growth rebound has been less than impressive. The Atlanta Fed’s real-time GDP estimate tracker currently pegs Q2 growth at +3.6% following this morning’s data, unchanged from before.

J.C. Penney (JCP) became the latest retailer this morning to disappoint with same-store sale data, which follows similar underperformance from Nordstrom (NYSE:JWN) (JWN), Macy’s (M) and Kohl’s (KSS) on Thursday. These reports reconfirm what we all knew all along – that these operators needed literally to reinvent their businesses to effectively compete with the likes of Amazon. A number of these retailers are still very profitable and have strong balance sheets, which will keep them around for a long time. So, Macy’s and Nordstrom aren’t going away, at least not any time soon. But for them to become thriving and growing operations again, they will not only need to aggressively shrink their brick-and-mortar footprint, but also stock up with differentiated merchandize.

We provide the Q1 earnings season scorecard below, but please note that this daily publication features the best research output of the Zacks analyst team. In today’s write-up, we are featuring analyst reports on 16 major stocks, including reports on Amazon (AMZN), Verizon (VZ), Citigroup (C ) and Amgen (AMGN). These reports have been hand-picked from amongst the 70 or so stock research reports published by our analyst team today. You can see all of today’s research reports here >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Q1 Earnings Season Scorecard (as of Thursday, May 12th)

Including this morning’s releases, we now have Q1 reports from 454 S&P 500 members and another 18 index members on deck to report results next week. Total earnings for these index members are up +13.9% from the same period last year on +7.9% higher revenues, with 72.3% beating EPS estimates and 65.9% beating revenue estimates. The proportion of companies beating both EPS and revenue estimates is 51.6%. As we have been saying all along, this better performance than we have seen from the same group of 454 index members in other recent periods.

For the Retail sector, we now have Q1 results from 24 of the 42 retailers in the S&P 500 index. Total earnings for these 24 retailers are up +2.2% from the same period last year on +4.6% higher revenues, with 58.3% beating EPS estimates and 54.2% beating revenue estimates.

Please note that we have a stand-alone Retail sector, unlike the official Standard & Poor’s placement of this space in the Consumer Discretionary sector. The Zacks Retail sector includes, besides the traditional department stores and other brick-and-mortar retailers, the online vendors like Amazon and Priceline and restaurant operators. Most of the 24 Zacks Retail sector companies that have reported Q1 results already at this stage are online vendors and restaurant players, with the traditional retail operators starting the reporting process with Thursday’s Macy’s disappointment that was maintained by Nordstrom after the market’s close on Thursday and JC Penney this morning.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The aggregate results from the 24 retailers that have reported Q1 results already are tracking below what we had seen from the same companies in other recent periods. This is despite the +41.1% growth in Amazon’s earnings on +22.6% higher revenues. On an ex-Amazon basis, the sector’s Q1 earnings growth would be modestly in the negative.

You can read more about our views about this earnings season in the weekly Earnings Trends report >>> Strong Earnings Season Winding Down

Today's Featured Stock Research Reports

Amazon’s shares have outperformed the broader market in the year-to-date period (the stock is up +26.4% vs. the +7.2% gain for the S&P 500 as a whole). The company delivered strong first quarter results with both earnings and revenues beating expectations. The Zacks analyst likes the company’s solid loyalty system in Prime and its FBA strategy, and content addition continues to add selection to Prime memberships. Also, the AWS generates much higher margins than retail, so it has a very positive impact on Amazon’s profitability. Devices and IoT is also a potential growth area. However, Prime saturation in the U.S. market and competition in online retail remains concern. (You can read the full research report on Amazon here >>>)

Shares of Verizon have been laggards over the past year - the stock is down -9.6% over the past 12 months vs. AT&T (NYSE:T)'s -1.8% decline and the +16.9% gain for the S&P 500 index. Verizon’s latest deal to acquire Straight Path Communications for $3.1 billion is part of its recent efforts to maintain its wireless leadership while branching out into adjacent opportunities. The company’s decision to launch FiOS Prepaid plan, FiOS Internet service and to zero-rate its data on FiOS Mobile App should help it gain subscribers while unlimited data plans have heated up the wireless industry. The Verizon-Yahoo deal underwent a discount revision of $350 million, but is part of the company's efforts to add content; a TV streaming service is reportedly being contemplated. In the updated research report issued today, the Zacks analyst discusses the pros & cons of investing in Verizon shares at this stage. (You can read the full research report on Verizon here >>>)

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Citigroup shares have gained around +2.1% year to date, outperforming the Zacks Major Banks industry, which has gained +1.5% over the same period. The company’s first-quarter 2017 earnings outpaced expectations on higher revenues. The Zacks analyst likes the company’s restructuring and streamlining efforts, strategic investments in core business and expense management and believes these actions should support profitability going forward. Uncertainty about regulatory overhaul and interest rates are concerns in the Citigroup story, as they are for all other major banks. (You can read the full research report on Citigroup here >>>)

Amgen shares struggled last year, but came back strong following the election as fears of restrictive pricing and regulatory strictures eased. The stock has been down in a big way since March 1st, but has still done better than the peer group over the past year. The Zacks analyst points out that Amgen remains well positioned for growth with several blockbuster drugs in its portfolio. Amgen’s growth products – Prolia, Xgeva, Vectibix, Nplate and Sensipar – are all performing well. Amgen is also progressing with its pipeline including biosimilar drugs, given quite a few regulatory and data updates scheduled for the coming quarters. However, the company has some challenges in store given the presence of biosimilar competition and slowdown in sales of mature products. Volume growth of new products may not be enough to offset the lost sales due to the decline in mature brands. (You can read the full research report on Amgen here >>>)

Other noteworthy reports we are featuring today include 21st Century Fox (FOXA), Eaton Corp. (ETN) and Sinopec (SNP).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

5 Trades Could Profit "Big-League" from Trump Policies If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>

Sheraz Mian

Director of Research


Featured Reports

21st Century Fox (FOXA) Tops Q3 Earnings, Revenues Lag

21st Century Fox posted earnings beat in third-quarter fiscal 2017 driven by solid performance of Cable and Television. Per the Zacks analyst, back-to-back revenue miss and higher costs are concerns.

Sinopec's (SNP) Earnings and Revenues Increase Y/Y in Q1

The covering nalyst agrees that higher oil price realizations as well as improved refinery throughput led Sinopec to post better Q1 earnings & revenue numbers.

T. Rowe Price (TROW) Poised To Growth, High Costs Linger

The covering analyst thinks though costs related to strategic initiatives puts pressure on T. Rowe Price's expenses, organic growth and diverse business model remain key strengths.

Eaton Corp. (ETN) Beats Q1 Earnings, Revenue Estimates

The Zacks analyst believes Eaton Corp was able to beat first-quarter earnings and total revenue estimates, thanks to growth in organic sales and revival in its end market.

Hologic (HOLX) Beats on Q2 Earnings; Raises 2017 Guidance

Per the Zacks analyst, Hologic performed well in Q2 on solid growth in molecular diagnostics, Surgical and Breast Health businesses. Management's raised guidance for fiscal 2017 also raises optimism.

Principal Financial (PFG) Q1 Earnings, Revenues Improve Y/Y

Principal Financial's earnings were aided by solid investment performance, expense control and growth in fee, spread, risk businesses.

Dr Pepper (DPS) Tops Q1 Earnings, Updates View

The Zacks analyst thinks solid execution, powerful marketing programs and productivity improvements will lead to solid growth.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
New Upgrades

Amdocs (DOX) Beats Q2 Earnings & Revenues, Updates View

Amdocs reported relatively healthy second-quarter fiscal 2017 results with modest year-over-year improvement in revenues and earnings that beat the respective Zacks Consensus Estimates.

Pitney Bowes (NYSE:PBI) Beats on Q1 Earnings, E-Commerce Thrives

Pitney Bowes Q1 earnings beat on diligent operational execution. A rebound in Software business, thriving ecommerce space and robust transformation initiatives will likely boost growth in times ahead.

CBOE Holdings (CBOE) Q1 Earnings Up on Higher Index Trading

CBOE Holdings' first quarter earnings beat estimates on sustained improvement in index trading. Also addition of Bats Global will expand and diversify product portfolio and boost margins.

New Downgrades

Pacira (PCRX) Posts Q1 Loss, Overdependance on Exparel

Pacira posted wider than expected loss in Q1 and missed on sales. The Zacks analyst believes that a decline in Exparel sales will adversely impact the company's top line, which remains a concern.

American Public (APEI) Lags Q1 Earnings, Enrollments Down

American Public Education's earnings missed expectation by 3.5%. Per the covering analyst, revenues are being hurt by soft enrollment trends at American Public University System and Hondros College.

Model N (MODN) Down on Intense Competition, Mounting Losses

According to the Zacks analyst, lack of international customers, mounting operating loss, continuing cash burn and stretched valuation are some of the headwinds for Model N.



Verizon Communications Inc. (NYSE:VZ

Macy's Inc (NYSE:M

Nordstrom, Inc. (JWN): Free Stock Analysis Report

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Citigroup Inc. (NYSE:C

Amazon.com, Inc. (NASDAQ:AMZN

Amgen Inc. (NASDAQ:AMGN

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.